The Food and Drug Administration is considering splitting doses of the Jynneos vaccine into fifths to increase supply amid the expanding monkeypox outbreak, FDA Commissioner Robert Califf said this week.
Driving the news: Under the "dose-sparing" approach, health care providers could use one vial of the vaccine to administer up to five doses without an impact on safety or efficacy, Califf said.
